Deployment of the human immunodeficiency virus type 1 protein arsenal: Combating the host to enhance viral transcription and providing targets for therapeutic development

Journal of General Virology

Volumn 93, Issue 6, 2012, Pages 1151-1172

  Dahiya, Satinder ^a   Nonnemacher, Michael R ^a   Wigdahl, Brian ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BETA INTERFERON; BUTHIONINE SULFOXIMINE; CCAAT ENHANCER BINDING PROTEIN BETA; GAG PROTEIN; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE INHIBITOR; HISTONE METHYLTRANSFERASE; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LENS EPITHELIUM DERIVED GROWTH FACTOR; LYMPHOID ENHANCER FACTOR 1; MATRIX PROTEIN; MICRORNA; NEF PROTEIN; PROTEIN KINASE C; STAT3 PROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR NFAT; VIF PROTEIN; VIRUS DNA; VIRUS PROTEIN; VPR PROTEIN; VPU PROTEIN;

BRAIN CELL; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL POPULATION; CHROMATIN; DENDRITIC CELL; DISEASE PREDISPOSITION; DNA METHYLATION; ENVELOPE GENE; ENZYME ACTIVITY; EX VIVO STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; IN VIVO STUDY; LIFE CYCLE; MACROPHAGE; MOLECULAR BIOLOGY; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA INTERACTION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; VIRUS GENE; VIRUS REPLICATION;

ANIMALS; ANTI-HIV AGENTS; GENE EXPRESSION REGULATION, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; VIRAL PROTEINS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84861176272     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.041186-0     Document Type: Review

References (188)

1. Ahluwalia, J. K., Khan, S. Z., Soni, K., Rawat, P., Gupta, A., Hariharan, M., Scaria, V., Lalwani, M., Pillai, B. & other authors (2008). Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology 5, 117.
2. Alexaki, A. & Wigdahl, B. (2008). HIV-1 infection of bone marrow hematopoietic progenitor cells and their role in trafficking and viral dissemination. PLoS Pathog 4, e1000215.
3. Alexaki, A., Liu, Y. & Wigdahl, B. (2008). Cellular reservoirs of HIV-1 and their role in viral persistence. Curr HIV Res 6, 388-400.
4. Ammosova, T., Obukhov, Y., Kotelkin, A., Breuer, D., Beullens, M., Gordeuk, V. R., Bollen, M. & Nekhai, S. (2011a). Protein phosphatase- 1 activates CDK9 by dephosphorylating Ser175. PLoS ONE 6, e18985.
5. Ammosova, T., Yedavalli, V. R., Niu, X., Jerebtsova, M., Van Eynde, A., Beullens, M., Bollen, M., Jeang, K. T. & Nekhai, S. (2011b). Expression of a protein phosphatase 1 inhibitor, cdNIPP1, increases CDK9 threonine 186 phosphorylation and inhibits HIV-1 transcription. J Biol Chem 286, 3798-3804.
6. Andersen, J. L., DeHart, J. L., Zimmerman, E. S., Ardon, O., Kim, B., Jacquot, G., Benichou, S. & Planelles, V. (2006). HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT. PLoS Pathog 2, e127.
7. Archin, N. M., Espeseth, A., Parker, D., Cheema, M., Hazuda, D. & Margolis, D. M. (2009). Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid. AIDS Res Hum Retroviruses 25, 207-212.
8. Ardon, O., Zimmerman, E. S., Andersen, J. L., DeHart, J. L., Blackett, J. & Planelles, V. (2006). Induction of G2 arrest and binding to cyclophilin A are independent phenotypes of human immunodeficiency virus type 1 Vpr. J Virol 80, 3694-3700.
9. Arold, S., Franken, P., Strub, M. P., Hoh, F., Benichou, S., Benarous, R. & Dumas, C. (1997). The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling. Structure 5, 1361-1372.
10. Bartlett, J. A., Miralles, G. D., Sevin, A. D., Silberman, M., Pruitt, S. K., Ottinger, J., Gryszowska, V., Fiscus, S. A., Bucy, R. P. & ACTG 380 Study Team (2002). Addition of cyclophosphamide to antiretroviral therapy does not diminish the cellular reservoir in HIV-infected persons. AIDS Res Hum Retroviruses 18, 535-543.
11. Baur, A. S. (2011). HIV-Nef and AIDS pathogenesis: are we barking up the wrong tree? Trends Microbiol 19, 435-440.
12. Bedoya, L. M., Márquez, N., Martínez, N., Gutiérrez-Eisman, S., Alvarez, A., Calzado, M. A., Rojas, J. M., Appendino, G., Muñoz, E. & Alcamí, J. (2009). SJ23B, a jatrophane diterpene activates classical PKCs and displays strong activity against HIV in vitro. Biochem Pharmacol 77, 965-978.
13. Bennasser, Y., Le, S. Y., Benkirane, M. & Jeang, K. T. (2005). Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 22, 607-619.
14. Bertin, J., Barat, C., Méthot, S. & Tremblay, M. J. (2012). Interactions between prostaglandins, leukotrienes and HIV-1: possible implications for the central nervous system. Retrovirology 9, 4.
15. + T-lymphocyte microRNA expression following exposure to HIV-1. Blood. doi: 10.1182/blood-2011-09-379503.
16. Blazkova, J., Trejbalova, K., Gondois-Rey, F., Halfon, P., Philibert, P., Guiguen, A., Verdin, E., Olive, D., Van Lint, C. & other authors (2009). CpG methylation controls reactivation of HIV from latency. PLoS Pathog 5, e1000554.
17. Bocklandt, S., Blumberg, P. M. & Hamer, D. H. (2003). Activation of latent HIV-1 expression by the potent anti-tumor promoter 12-deoxyphorbol 13-phenylacetate. Antiviral Res 59, 89-98.
18. Borjabad, A., Brooks, A. I. & Volsky, D. J. (2010). Gene expression profiles of HIV-1-infected glia and brain: toward better understanding of the role of astrocytes in HIV-1-associated neurocognitive disorders. J Neuroimmune Pharmacol 5, 44-62.
19. Boven, L. A., Noorbakhsh, F., Bouma, G., van der Zee, R., Vargas, D. L., Pardo, C., McArthur, J. C., Nottet, H. S. & Power, C. (2007). Brain-derived human immunodeficiency virus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation. J Neurovirol 13, 173-184.
20. Brass, A. L., Dykxhoorn, D. M., Benita, Y., Yan, N., Engelman, A., Xavier, R. J., Lieberman, J. & Elledge, S. J. (2008). Identification of host proteins required for HIV infection through a functionalgenomic screen. Science 319, 921-926.
21. Brigati, C., Giacca, M., Noonan, D. M. & Albini, A. (2003). HIV Tat, its TARgets and the control of viral gene expression. FEMS Microbiol Lett 220, 57-65.
22. Bukrinskaya, A. (2007). HIV-1 matrix protein: a mysterious regulator of the viral life cycle. Virus Res 124, 1-11.
23. Burdo, T. H., Nonnemacher, M., Irish, B. P., Choi, C. H., Krebs, F. C., Gartner, S. & Wigdahl, B. (2004). High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-κB sites within the HIV-1 LTR correlate with HIV-1-associated dementia. DNA Cell Biol 23, 261-269.
24. Burnett, J. C., Lim, K. I., Calafi, A., Rossi, J. J., Schaffer, D. V. & Arkin, A. P. (2010). Combinatorial latency reactivation for HIV-1 subtypes and variants. J Virol 84, 5958-5974.
25. Chable-Bessia, C., Meziane, O., Latreille, D., Triboulet, R., Zamborlini, A., Wagschal, A., Jacquet, J. M., Reynes, J., Levy, Y. & other authors (2009). Suppression of HIV-1 replication by microRNA effectors. Retrovirology 6, 26.
26. + T lymphocytes. J Virol 86, 3244-3252.
27. + T cells. Nature 435, 108-114.
28. Choudhary, S. K. & Margolis, D. M. (2011). Curing HIV: pharmacologic approaches to target HIV-1 latency. Annu Rev Pharmacol Toxicol 51, 397-418.
29. Christensen, H. S., Daher, A., Soye, K. J., Frankel, L. B., Alexander, M. R., Lainé, S., Bannwarth, S., Ong, C. L., Chung, S. W. & other authors (2007). Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production. J Virol 81, 5121-5131.
30. Chun, T. W., Carruth, L., Finzi, D., Shen, X., DiGiuseppe, J. A., Taylor, H., Hermankova, M., Chadwick, K., Margolick, J. & other authors (1997). Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387, 183-188.
31. + T cells during primary HIV-1 infection. Proc Natl Acad Sci U S A 95, 8869-8873.
32. Chun, T. W., Nickle, D. C., Justement, J. S., Meyers, J. H., Roby, G., Hallahan, C. W., Kottilil, S., Moir, S., Mican, J. M. & other authors (2008). Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. J Infect Dis 197, 714-720.
33. Ciuffi, A., Llano, M., Poeschla, E., Hoffmann, C., Leipzig, J., Shinn, P., Ecker, J. R. & Bushman, F. (2005). A role for LEDGF/p75 in targeting HIV DNA integration. Nat Med 11, 1287-1289.
34. Clements, J. E., Gama, L., Graham, D. R., Mankowski, J. L. & Zink, M. C. (2011). A simian immunodeficiency virus macaque model of highly active antiretroviral treatment: viral latency in the periphery and the central nervous system. Curr Opin HIV AIDS 6, 37-42.
35. Cobos-Jiménez, V., Booiman, T., Hamann, J. & Kootstra, N. A. (2011). Macrophages and HIV-1. Curr Opin HIV AIDS 6, 385-390.
36. Coleman, C. M. & Wu, L. (2009). HIV interactions with monocytes and dendritic cells: viral latency and reservoirs. Retrovirology 6, 51.
37. Colin, L. & Van Lint, C. (2009). Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies. Retrovirology 6, 111.
38. Corbeau, P. (2008). Interfering RNA and HIV: reciprocal interferences. PLoS Pathog 4, e1000162.
39. Davis, L. E., Hjelle, B. L., Miller, V. E., Palmer, D. L., Llewellyn, A. L., Merlin, T. L., Young, S. A., Mills, R. G., Wachsman, W. & Wiley, C. A. (1992). Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 42, 1736-1739.
40. Demarchi, F., Gutierrez, M. I. & Giacca, M. (1999). Human immunodeficiency virus type 1 Tat protein activates transcription factor NF-κB through the cellular interferon-inducible, doublestranded RNA-dependent protein kinase, PKR. J Virol 73, 7080-7086.
41. Deng, L., Wang, D., de la Fuente, C., Wang, L., Li, H., Lee, C. G., Donnelly, R., Wade, J. D., Lambert, P. & Kashanchi, F. (2001). Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA. Virology 289, 312-326.
42. Deshmane, S. L., Mukerjee, R., Fan, S., Del Valle, L., Michiels, C., Sweet, T., Rom, I., Khalili, K., Rappaport, J. & other authors (2009). Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1a expression. J Biol Chem 284, 11364-11373.
43. Dong, C., Kwas, C. & Wu, L. (2009). Transcriptional restriction of human immunodeficiency virus type 1 gene expression in undifferentiated primary monocytes. J Virol 83, 3518-3527.
44. du Chéné, I., Basyuk, E., Lin, Y. L., Triboulet, R., Knezevich, A., Chable-Bessia, C., Mettling, C., Baillat, V., Reynes, J. & other authors (2007). Suv39H1 and HP1c are responsible for chromatinmediated HIV-1 transcriptional silencing and post-integration latency. EMBO J 26, 424-435.
45. Easley, R., Van Duyne, R., Coley, W., Guendel, I., Dadgar, S., Kehn-Hall, K. & Kashanchi, F. (2010). Chromatin dynamics associated with HIV-1 Tat-activated transcription. Biochim Biophys Acta 1799, 275-285.
46. + T cells. J Exp Med 194, 1407-1419.
47. Epie, N., Ammosova, T., Turner, W. & Nekhai, S. (2006). Inhibition of PP2A by LIS1 increases HIV-1 gene expression. Retrovirology 3, 65.
48. Eugenin, E. A., Clements, J. E., Zink, M. C. & Berman, J. W. (2011). Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism. J Neurosci 31, 9456-9465.
49. Fenard, D., Yonemoto, W., de Noronha, C., Cavrois, M., Williams, S. A. & Greene, W. C. (2005). Nef is physically recruited into the immunological synapse and potentiates T cell activation early after TCR engagement. J Immunol 175, 6050-6057.
50. Fenyö, E. M., Morfeldt-Månson, L., Chiodi, F., Lind, B., von Gegerfelt, A., Albert, J., Olausson, E. & Asjö, B. (1988). Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J Virol 62, 4414-4419.
51. Fiorentini, S., Giagulli, C., Caccuri, F., Magiera, A. K. & Caruso, A. (2010). HIV-1 matrix protein p17: a candidate antigen for therapeutic vaccines against AIDS. Pharmacol Ther 128, 433-444.
52. + T cells requires Nef and Tat virus gene products and results from higher NFAT, NF-κB, and AP-1 induction. J Biol Chem 279, 39520-39531.
53. Futaki, S., Suzuki, T., Ohashi, W., Yagami, T., Tanaka, S., Ueda, K. & Sugiura, Y. (2001). Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 276, 5836-5840.
54. Gatignol, A., Lainé, S. & Clerzius, G. (2005). Dual role of TRBP in HIV replication and RNA interference: viral diversion of a cellular pathway or evasion from antiviral immunity? Retrovirology 2, 65.
55. Giagulli, C., Marsico, S., Magiera, A. K., Bruno, R., Caccuri, F., Barone, I., Fiorentini, S., Andò, S. & Caruso, A. (2011). Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells. PLoS ONE 6, e17831.
56. Haasnoot, J., de Vries, W., Geutjes, E. J., Prins, M., de Haan, P. & Berkhout, B. (2007). The Ebola virus VP35 protein is a suppressor of RNA silencing. PLoS Pathog 3, e86.
57. Hakre, S., Chavez, L., Shirakawa, K. & Verdin, E. (2011). Epigenetic regulation of HIV latency. Curr Opin HIV AIDS 6, 19-24.
58. Hariharan, M., Scaria, V., Pillai, B. & Brahmachari, S. K. (2005). Targets for human encoded microRNAs in HIV genes. Biochem Biophys Res Commun 337, 1214-1218.
59. Hayes, A. M., Qian, S., Yu, L. & Boris-Lawrie, K. (2011). Tat RNA silencing suppressor activity contributes to perturbation of lymphocyte miRNA by HIV-1. Retrovirology 8, 36.
60. + T cells. Proc Natl Acad Sci U S A 94, 8714-8719.
61. Herbein, G. & Varin, A. (2010). The macrophage in HIV-1 infection: from activation to deactivation? Retrovirology 7, 33.
62. Herbein, G., Gras, G., Khan, K. A. & Abbas, W. (2010). Macrophage signaling in HIV-1 infection. Retrovirology 7, 34.
63. Hogan, T. H., Nonnemacher, M. R., Krebs, F. C., Henderson, A. & Wigdahl, B. (2003). HIV-1 Vpr binding to HIV-1 LTR C/EBP cisacting elements and adjacent regions is sequence-specific. Biomed Pharmacother 57, 41-48.
64. Honda, Y., Rogers, L., Nakata, K., Zhao, B. Y., Pine, R., Nakai, Y., Kurosu, K., Rom, W. N. & Weiden, M. (1998). Type I interferon induces inhibitory 16-kD CCAAT/enhancer binding protein (C/EBP)β, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication. J Exp Med 188, 1255-1265.
65. Horiba, M., Martinez, L. B., Buescher, J. L., Sato, S., Limoges, J., Jiang, Y., Jones, C. & Ikezu, T. (2007). OTK18, a zinc-finger protein, regulates human immunodeficiency virus type 1 long terminal repeat through two distinct regulatory regions. J Gen Virol 88, 236-241.
66. Hoshino, Y., Nakata, K., Hoshino, S., Honda, Y., Tse, D. B., Shioda, T., Rom, W. N. & Weiden, M. (2002). Maximal HIV-1 replication in alveolar macrophages during tuberculosis requires both lymphocyte contact and cytokines. J Exp Med 195, 495-505.
67. Houzet, L. & Jeang, K. T. (2011). MicroRNAs and human retroviruses. Biochim Biophys Acta 1809, 686-693.
68. Houzet, L., Morichaud, Z., Didierlaurent, L., Muriaux, D., Darlix, J. L. & Mougel, M. (2008). Nucleocapsid mutations turn HIV-1 into a DNAcontaining virus. Nucleic Acids Res 36, 2311-2319.
69. Howcroft, T. K., Strebel, K., Martin, M. A. & Singer, D. S. (1993). Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science 260, 1320-1322.
70. + T lymphocytes. Nat Med 13, 1241-1247.
71. + T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): implications for HIV-1 infections of humans. Proc Natl Acad Sci U S A 98, 658-663.
72. Jäger, S., Cimermancic, P., Gulbahce, N., Johnson, J. R., McGovern, K. E., Clarke, S. C., Shales, M., Mercenne, G., Pache, L. & other authors (2012). Global landscape of HIV-human protein complexes. Nature 481, 365-370.
73. Jeang, K. T., Berkhout, B. & Dropulic, B. (1993). Effects of integration and replication on transcription of the HIV-1 long terminal repeat. J Biol Chem 268, 24940-24949.
74. Karn, J. (2011). The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit. Curr Opin HIV AIDS 6, 4-11.
75. Kauder, S. E., Bosque, A., Lindqvist, A., Planelles, V. & Verdin, E. (2009). Epigenetic regulation of HIV-1 latency by cytosine methylation. PLoS Pathog 5, e1000495.
76. Kilareski, E. M., Shah, S., Nonnemacher, M. R. & Wigdahl, B. (2009). Regulation of HIV-1 transcription in cells of the monocytemacrophage lineage. Retrovirology 6, 118.
77. Kim, H. J., Martemyanov, K. A. & Thayer, S. A. (2008a). Human immunodeficiency virus protein Tat induces synapse loss via a reversible process that is distinct from cell death. J Neurosci 28, 12604-12613.
78. Kim, S. A., Chang, S., Yoon, J. H. & Ahn, S. G. (2008b). TAT-Hsp40 inhibits oxidative stress-mediated cytotoxicity via the inhibition of Hsp70 ubiquitination. FEBS Lett 582, 734-740.
79. + T cells. PLoS Pathog 6, e1001103.
80. Kino, T. & Pavlakis, G. N. (2004). Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1. DNA Cell Biol 23, 193-205.
81. Kino, T., Gragerov, A., Kopp, J. B., Stauber, R. H., Pavlakis, G. N. & Chrousos, G. P. (1999). The HIV-1 virion-associated protein Vpr is a coactivator of the human glucocorticoid receptor. J Exp Med 189, 51-62.
82. Kirchhoff, F. (2010). Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe 8, 55-67.
83. Klase, Z., Kale, P., Winograd, R., Gupta, M. V., Heydarian, M., Berro, R., McCaffrey, T. & Kashanchi, F. (2007). HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR. BMC Mol Biol 8, 63.
84. Klase, Z., Winograd, R., Davis, J., Carpio, L., Hildreth, R., Heydarian, M., Fu, S., McCaffrey, T., Meiri, E. & other authors (2009). HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression. Retrovirology 6, 18.
85. Klichko, V., Archin, N., Kaur, R., Lehrman, G. & Margolis, D. (2006). Hexamethylbisacetamide remodels the human immunodeficiency virus type 1 (HIV-1) promoter and induces Tat-independent HIV-1 expression but blunts cell activation. J Virol 80, 4570-4579.
86. Kogan, M. & Rappaport, J. (2011). HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention. Retrovirology 8, 25.
87. Komuro, I., Yokota, Y., Yasuda, S., Iwamoto, A. & Kagawa, K. S. (2003). CSF-induced and HIV-1-mediated distinct regulation of Hck and C/EBPb represent a heterogeneous susceptibility of monocyte-derived macrophages to M-tropic HIV-1 infection. J Exp Med 198, 443-453.
88. König, R., Zhou, Y., Elleder, D., Diamond, T. L., Bonamy, G. M., Irelan, J. T., Chiang, C. Y., Tu, B. P., De Jesus, P. D. & other authors (2008). Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135, 49-60.
89. Krautkrämer, E., Giese, S. I., Gasteier, J. E., Muranyi, W. & Fackler, O. T. (2004). Human immunodeficiency virus type 1 Nef activates p21-activated kinase via recruitment into lipid rafts. J Virol 78, 4085-4097.
90. Kulkosky, J., Culnan, D. M., Roman, J., Dornadula, G., Schnell, M., Boyd, M. R. & Pomerantz, R. J. (2001). Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART. Blood 98, 3006-3015.
91. Kutney, S. N., Hong, R., Macfarlan, T. & Chakravarti, D. (2004). A signaling role of histone-binding proteins and INHAT subunits pp32 and Set/TAF-Iβ in integrating chromatin hypoacetylation and transcriptional repression. J Biol Chem 279, 30850-30855.
92. Le Douce, V., Herbein, G., Rohr, O. & Schwartz, C. (2010). Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage. Retrovirology 7, 32.
93. Lee, E. S., Sarma, D., Zhou, H. & Henderson, A. J. (2002). CCAAT/enhancer binding proteins are not required for HIV-1 entry but regulate proviral transcription by recruiting coactivators to the longterminal repeat in monocytic cells. Virology 299, 20-31.
94. Levy, D. N., Refaeli, Y. & Weiner, D. B. (1995). Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. J Virol 69, 1243-1252.
95. Lewinski, M. K., Bisgrove, D., Shinn, P., Chen, H., Hoffmann, C., Hannenhalli, S., Verdin, E., Berry, C. C., Ecker, J. R. & Bushman, F. D. (2005). Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. J Virol 79, 6610-6619.
96. Li, J. C., Lee, D. C., Cheung, B. K. & Lau, A. S. (2005). Mechanisms for HIV Tat upregulation of IL-10 and other cytokine expression: kinase signaling and PKR-mediated immune response. FEBS Lett 579, 3055-3062.
97. Li, L., Aiamkitsumrit, B., Pirrone, V., Nonnemacher, M. R., Wojno, A., Passic, S., Flaig, K., Kilareski, E., Blakey, B. & other authors (2011). Development of co-selected single nucleotide polymorphisms in the viral promoter precedes the onset of human immunodeficiency virus type 1-associated neurocognitive impairment. J Neurovirol 17, 92-109.
98. Lisziewicz, J., Foli, A., Wainberg, M. & Lori, F. (2003). Hydroxyurea in the treatment of HIV infection: clinical efficacy and safety concerns. Drug Saf 26, 605-624.
99. Liu, Y., Nonnemacher, M. R., Stauff, D. L., Li, L., Banerjee, A., Irish, B., Kilareski, E., Rajagopalan, N., Suchitra, J. B. & other authors (2010). Structural and functional studies of CCAAT/enhancer binding sites within the human immunodeficiency virus type 1 subtype C LTR. Biomed Pharmacother 64, 672-680.
100. López-Huertas, M. R., Callejas, S., Abia, D., Mateos, E., Dopazo, A., Alcamí, J. & Coiras, M. (2010). Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 Tat protein are greatly dependent on the second coding exon. Nucleic Acids Res 38, 3287-3307.
101. + T cells. J Exp Med 201, 2023-2033.
102. Lori, F., Malykh, A., Cara, A., Sun, D., Weinstein, J. N., Lisziewicz, J. & Gallo, R. C. (1994). Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication. Science 266, 801-805.
103. Lu, S. & Cullen, B. R. (2004). Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and microRNA biogenesis. J Virol 78, 12868-12876.
104. Lusic, M., Marcello, A., Cereseto, A. & Giacca, M. (2003). Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter. EMBO J 22, 6550-6561.
105. Malim, M. H. (2009). APOBEC proteins and intrinsic resistance to HIV-1 infection. Philos Trans R Soc Lond B Biol Sci 364, 675-687.
106. Malim, M. H. & Emerman, M. (2008). HIV-1 accessory proteins-ensuring viral survival in a hostile environment. Cell Host Microbe 3, 388-398.
107. Margolis, D. M. (2011). Histone deacetylase inhibitors and HIV latency. Curr Opin HIV AIDS 6, 25-29.
108. Marini, E., Tiberio, L., Caracciolo, S., Tosti, G., Guzman, C. A., Schiaffonati, L., Fiorentini, S. & Caruso, A. (2008). HIV-1 matrix protein p17 binds to monocytes and selectively stimulates MCP-1 secretion: role of transcriptional factor AP-1. Cell Microbiol 10, 655-666.
109. Mascarenhas, A. P. & Musier-Forsyth, K. (2009). The capsid protein of human immunodeficiency virus: interactions of HIV-1 capsid with host protein factors. FEBS J 276, 6118-6127.
110. McNamara, L. A. & Collins, K. L. (2011). Hematopoietic stem/precursor cells as HIV reservoirs. Curr Opin HIV AIDS 6, 43-48.
111. Morris, K. V. (2005). siRNA-mediated transcriptional gene silencing: the potential mechanism and a possible role in the histone code. Cell Mol Life Sci 62, 3057-3066.
112. Mukerjee, R., Chang, J. R., Del Valle, L., Bagashev, A., Gayed, M. M., Lyde, R. B., Hawkins, B. J., Brailoiu, E., Cohen, E. & other authors (2011). Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders. J Biol Chem 286, 34976-34985.
113. Na, H., Acharjee, S., Jones, G., Vivithanaporn, P., Noorbakhsh, F., McFarlane, N., Maingat, F., Ballanyi, K., Pardo, C. A. & other authors (2011). Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence. Retrovirology 8, 44.
114. Narasipura, S. D., Henderson, L. J., Fu, S. W., Chen, L., Kashanchi, F. & Al-Harthi, L. (2012). Role of β-catenin and TCF/LEF family members in transcriptional activity of HIV in astrocytes. J Virol 86, 1911-1921.
115. Narayanan, A., Kehn-Hall, K., Bailey, C. & Kashanchi, F. (2011). Analysis of the roles of HIV-derived microRNAs. Expert Opin Biol Ther 11, 17-29.
116. Nathans, R., Chu, C. Y., Serquina, A. K., Lu, C. C., Cao, H. & Rana, T. M. (2009). Cellular microRNA and P bodies modulate host-HIV-1 interactions. Mol Cell 34, 696-709.
117. + T lymphocytes. Virology 410, 316-326.
118. Neuveut, C. & Jeang, K. T. (1996). Recombinant human immunodeficiency virus type 1 genomes with Tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture. J Virol 70, 5572-5581.
119. Olivieri, K. C., Mukerji, J. & Gabuzda, D. (2011). Nef-mediated enhancement of cellular activation and human immunodeficiency virus type 1 replication in primary T cells is dependent on association with p21-activated kinase 2. Retrovirology 8, 64.
120. Omoto, S. & Fujii, Y. R. (2005). Regulation of human immunodeficiency virus 1 transcription by nef microRNA. J Gen Virol 86, 751-755.
121. Omoto, S., Ito, M., Tsutsumi, Y., Ichikawa, Y., Okuyama, H., Brisibe, E. A., Saksena, N. K. & Fujii, Y. R. (2004). HIV-1 nef suppression by virally encoded microRNA. Retrovirology 1, 44.
122. Orenstein, J. M., Meltzer, M. S., Phipps, T. & Gendelman, H. E. (1988). Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colonystimulating factor-1-treated human monocytes: an ultrastructural study. J Virol 62, 2578-2586.
123. Orenstein, J. M., Fox, C. & Wahl, S. M. (1997). Macrophages as a source of HIV during opportunistic infections. Science 276, 1857-1861.
124. Ouellet, D. L., Plante, I., Barat, C., Tremblay, M. J. & Provost, P. (2009). Emergence of a complex relationship between HIV-1 and the microRNA pathway. Methods Mol Biol 487, 415-433.
125. Pearson, R., Kim, Y. K., Hokello, J., Lassen, K., Friedman, J., Tyagi, M. & Karn, J. (2008). Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency. J Virol 82, 12291-12303.
126. Peterlin, B. M. & Price, D. H. (2006). Controlling the elongation phase of transcription with P-TEFb. Mol Cell 23, 297-305.
127. Piller, S. C., Jans, P., Gage, P. W. & Jans, D. A. (1998). Extracellular HIV-1 virus protein R causes a large inward current and cell death in cultured hippocampal neurons: implications for AIDS pathology. Proc Natl Acad Sci U S A 95, 4595-4600.
128. Ping, Y. H. & Rana, T. M. (2001). DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation. J Biol Chem 276, 12951-12958.
129. Qian, S., Zhong, X., Yu, L., Ding, B., de Haan, P. & Boris-Lawrie, K. (2009). HIV-1 Tat RNA silencing suppressor activity is conserved across kingdoms and counteracts translational repression of HIV-1. Proc Natl Acad Sci U S A 106, 605-610.
130. Quivy, V., De Walque, S. & Van Lint, C. (2007). Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies. Subcell Biochem 41, 371-396.
131. Ranjbar, S., Tsytsykova, A. V., Lee, S. K., Rajsbaum, R., Falvo, J. V., Lieberman, J., Shankar, P. & Goldfeld, A. E. (2006). NFAT5 regulates HIV-1 in primary monocytes via a highly conserved long terminal repeat site. PLoS Pathog 2, e130.
132. Rauch, S., Pulkkinen, K., Saksela, K. & Fackler, O. T. (2008). Human immunodeficiency virus type 1 Nef recruits the guanine exchange factor Vav1 via an unexpected interface into plasma membrane microdomains for association with p21-activated kinase 2 activity. J Virol 82, 2918-2929.
133. Ravimohan, S., Gama, L., Barber, S. A. & Clements, J. E. (2010). Regulation of SIV mac 239 basal long terminal repeat activity and viral replication in macrophages: functional roles of two CCAAT/enhancer-binding protein beta sites in activation and interferon betamediated suppression. J Biol Chem 285, 2258-2273.
134. Refaeli, Y., Levy, D. N. & Weiner, D. B. (1995). The glucocorticoid receptor type II complex is a target of the HIV-1 Vpr gene product. Proc Natl Acad Sci U S A 92, 3621-3625.
135. Reuse, S., Calao, M., Kabeya, K., Guiguen, A., Gatot, J. S., Quivy, V., Vanhulle, C., Lamine, A., Vaira, D. & other authors (2009). Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection. PLoS ONE 4, e6093.
136. Roeth, J. F. & Collins, K. L. (2006). Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways. Microbiol Mol Biol Rev 70, 548-563.
137. Rohr, O., Marban, C., Aunis, D. & Schaeffer, E. (2003). Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells. J Leukoc Biol 74, 736-749.
138. Rom, S., Rom, I., Passiatore, G., Pacifici, M., Radhakrishnan, S., Del Valle, L., Piña-Oviedo, S., Khalili, K., Eletto, D. & Peruzzi, F. (2010). CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells. FASEB J 24, 2292-2300.
139. Ross, H. L., Gartner, S., McArthur, J. C., Corboy, J. R., McAllister, J. J., Millhouse, S. & Wigdahl, B. (2001). HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity. J Neurovirol 7, 235-249.
140. Rossi, A., Mukerjee, R., Ferrante, P., Khalili, K., Amini, S. & Sawaya, B. E. (2006). Human immunodeficiency virus type 1 Tat prevents dephosphorylation of Sp1 by TCF-4 in astrocytes. J Gen Virol 87, 1613-1623.
141. Sánchez-Del Cojo, M., López-Huertas, M. R., Mateos, E., Alcamí, J. & Coiras, M. (2011). Mechanisms of RNA interference in the HIV-1-host cell interplay. AIDS Rev 13, 149-160.
142. Sanghvi, V. R. & Steel, L. F. (2011). A re-examination of global suppression of RNA interference by HIV-1. PLoS ONE 6, e17246.
143. Sato, K. & Koyanagi, Y. (2011). The mouse is out of the bag: insights and perspectives on HIV-1-infected humanized mouse models. Exp Biol Med (Maywood) 236, 977-985.
144. Savarino, A., Mai, A., Norelli, S., El Daker, S., Valente, S., Rotili, D., Altucci, L., Palamara, A. T. & Garaci, E. (2009). "Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence. Retrovirology 6, 52.
145. Schnettler, E., de Vries, W., Hemmes, H., Haasnoot, J., Kormelink, R., Goldbach, R. & Berkhout, B. (2009). The NS3 protein of rice hoja blanca virus complements the RNAi suppressor function of HIV-1 Tat. EMBO Rep 10, 258-263.
146. Schopman, N. C., Willemsen, M., Liu, Y. P., Bradley, T., van Kampen, A., Baas, F., Berkhout, B. & Haasnoot, J. (2012). Deep sequencing of virus-infected cells reveals HIV-encoded small RNAs. Nucleic Acids Res 40, 414-427.
147. Schröder, A. R., Shinn, P., Chen, H., Berry, C., Ecker, J. R. & Bushman, F. (2002). HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110, 521-529.
148. Seelamgari, A., Maddukuri, A., Berro, R., de la Fuente, C., Kehn, K., Deng, L., Dadgar, S., Bottazzi, M. E., Ghedin, E. & other authors (2004). Role of viral regulatory and accessory proteins in HIV-1 replication. Front Biosci 9, 2388-2413.
149. Sherman, M. P., Schubert, U., Williams, S. A., de Noronha, C. M., Kreisberg, J. F., Henklein, P. & Greene, W. C. (2002). HIV-1 Vpr displays natural protein-transducing properties: implications for viral pathogenesis. Virology 302, 95-105.
150. Simmons, A., Gangadharan, B., Hodges, A., Sharrocks, K., Prabhakar, S., García, A., Dwek, R., Zitzmann, N. & McMichael, A. (2005). Nef-mediated lipid raft exclusion of UbcH7 inhibits Cbl activity in T cells to positively regulate signaling. Immunity 23, 621-634.
151. Sloan, R. D., Donahue, D. A., Kuhl, B. D., Bar-Magen, T. & Wainberg, M. A. (2010). Expression of Nef from unintegrated HIV-1 DNA downregulates cell surface CXCR4 and CCR5 on T-lymphocytes. Retrovirology 7, 44.
152. Solas, C., Lafeuillade, A., Halfon, P., Chadapaud, S., Hittinger, G. & Lacarelle, B. (2003). Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 47, 238-243.
153. Strazza, M., Pirrone, V., Wigdahl, B. & Nonnemacher, M. R. (2011). Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier. Brain Res 1399, 96-115.
154. Subbramanian, R. A., Xu, J., Toma, E., Morisset, R., Cohen, E. A., Menezes, J. & Ahmad, A. (2002). Comparison of human immunodeficiency virus (HIV)-specific infection-enhancing and -inhibiting antibodies in AIDS patients. J Clin Microbiol 40, 2141-2146.
155. Sun, G., Li, H., Wu, X., Covarrubias, M., Scherer, L., Meinking, K., Luk, B., Chomchan, P., Alluin, J. & other authors (2011). Interplay between HIV-1 infection and host microRNAs. Nucleic Acids Res
156. Sung, T. L. & Rice, A. P. (2009). miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1. PLoS Pathog 5, e1000263.
157. Swingler, S., Brichacek, B., Jacque, J. M., Ulich, C., Zhou, J. & Stevenson, M. (2003). HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection. Nature 424, 213-219.
158. Tahirov, T. H., Babayeva, N. D., Varzavand, K., Cooper, J. J., Sedore, S. C. & Price, D. H. (2010). Crystal structure of HIV-1 Tat complexed with human P-TEFb. Nature 465, 747-751.
159. Tanaka, N., Hoshino, Y., Gold, J., Hoshino, S., Martiniuk, F., Kurata, T., Pine, R., Levy, D., Rom, W. N. & Weiden, M. (2005). Interleukin-10 induces inhibitory C/EBPb through STAT-3 and represses HIV-1 transcription in macrophages. Am J Respir Cell Mol Biol 33, 406-411.
160. Trible, R. P., Emert-Sedlak, L. & Smithgall, T. E. (2006). HIV-1 Nef selectively activates Src family kinases Hck, Lyn, and c-Src through direct SH3 domain interaction. J Biol Chem 281, 27029-27038.
161. Triboulet, R., Mari, B., Lin, Y. L., Chable-Bessia, C., Bennasser, Y., Lebrigand, K., Cardinaud, B., Maurin, T., Barbry, P. & other authors (2007). Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 315, 1579-1582.
162. Tyagi, M., Rusnati, M., Presta, M. & Giacca, M. (2001). Internalization of HIV-1 Tat requires cell surface heparan sulfate proteoglycans. J Biol Chem 276, 3254-3261.
163. + cells is due to epigenetic transcriptional silencing and P-TEFb restriction. J Virol 84, 6425-6437.
164. Van Duyne, R., Easley, R., Wu, W., Berro, R., Pedati, C., Klase, Z., Kehn-Hall, K., Flynn, E. K., Symer, D. E. & Kashanchi, F. (2008). Lysine methylation of HIV-1 Tat regulates transcriptional activity of the viral LTR. Retrovirology 5, 40.
165. Van Lint, C. (2000). Role of chromatin in HIV-1 transcriptional regulation. Adv Pharmacol 48, 121-160.
166. Vardabasso, C., Manganaro, L., Lusic, M., Marcello, A. & Giacca, M. (2008). The histone chaperone protein nucleosome assembly protein-1 (hNAP-1) binds HIV-1 Tat and promotes viral transcription. Retrovirology 5, 8.
167. Varin, A., Decrion, A. Z., Sabbah, E., Quivy, V., Sire, J., Van Lint, C., Roques, B. P., Aggarwal, B. B. & Herbein, G. (2005). Synthetic Vpr protein activates activator protein-1, c-Jun N-terminal kinase, and NF-κB and stimulates HIV-1 transcription in promonocytic cells and primary macrophages. J Biol Chem 280, 42557-42567.
168. Verschure, P. J., Visser, A. E. & Rots, M. G. (2006). Step out of the groove: epigenetic gene control systems and engineered transcription factors. Adv Genet 56, 163-204.
169. Vlach, J., Garcia, A., Jacqué, J. M., Rodriguez, M. S., Michelson, S. & Virelizier, J. L. (1995). Induction of Sp1 phosphorylation and NF-κB-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid. Virology 208, 753-761.
170. Wang, X., Ye, L., Hou, W., Zhou, Y., Wang, Y. J., Metzger, D. S. & Ho, W. Z. (2009). Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood 113, 671-674.
171. Weinberg, J. B., Matthews, T. J., Cullen, B. R. & Malim, M. H. (1991). Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes. J Exp Med 174, 1477-1482.
172. Weinberger, L. S., Burnett, J. C., Toettcher, J. E., Arkin, A. P. & Schaffer, D. V. (2005). Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity. Cell 122, 169-182.
173. Weinberger, L. S., Dar, R. D. & Simpson, M. L. (2008). Transientmediated fate determination in a transcriptional circuit of HIV. Nat Genet 40, 466-470.
174. Williams, S. A. & Greene, W. C. (2007). Regulation of HIV-1 latency by T-cell activation. Cytokine 39, 63-74.
175. + T-cell count in HIV-1-infected elite suppressors and viremic patients. Retrovirology 9, 5.
176. Wong, K., Sharma, A., Awasthi, S., Matlock, E. F., Rogers, L., Van Lint, C., Skiest, D. J., Burns, D. K. & Harrod, R. (2005). HIV-1 Tat interactions with p300 and PCAF transcriptional coactivators inhibit histone acetylation and neurotrophin signaling through CREB. J Biol Chem 280, 9390-9399.
177. Wu, L. P., Wang, X., Li, L., Zhao, Y., Lu, S., Yu, Y., Zhou, W., Liu, X., Yang, J. & other authors (2008). Histone deacetylase inhibitor depsipeptide activates silenced genes through decreasing both CpG and H3K9 methylation on the promoter. Mol Cell Biol 28, 3219-3235.
178. Yan, N., Cherepanov, P., Daigle, J. E., Engelman, A. & Lieberman, J. (2009). The SET complex acts as a barrier to autointegration of HIV-1. PLoS Pathog 5, e1000327.
179. Yang, H. C., Shen, L., Siliciano, R. F. & Pomerantz, J. L. (2009a). Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation. Proc Natl Acad Sci U S A 106, 6321-6326.
180. Yang, H. C., Xing, S., Shan, L., O'Connell, K., Dinoso, J., Shen, A., Zhou, Y., Shrum, C. K., Han, Y. & other authors (2009b). Smallmolecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation. J Clin Invest 119, 3473-3486.
181. Yeung, M. L., Bennasser, Y., Myers, T. G., Jiang, G., Benkirane, M. & Jeang, K. T. (2005). Changes in microRNA expression profiles in HIV-1-transfected human cells. Retrovirology 2, 81.
182. Yeung, M. L., Houzet, L., Yedavalli, V. S. & Jeang, K. T. (2009a). A genome-wide short hairpin RNA screening of jurkat T-cells for human proteins contributing to productive HIV-1 replication. J Biol Chem 284, 19463-19473.
183. Yeung, M. L., Bennasser, Y., Watashi, K., Le, S. Y., Houzet, L. & Jeang, K. T. (2009b). Pyrosequencing of small non-coding RNAs in HIV-1 infected cells: evidence for the processing of a viral-cellular double-stranded RNA hybrid. Nucleic Acids Res 37, 6575-6586.
184. Ylisastigui, L., Archin, N. M., Lehrman, G., Bosch, R. J. & Margolis, D. M. (2004). Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression. AIDS 18, 1101-1108.
185. + T cells are enriched for HIV-1 Tat variants with impaired transactivation activity. Virology 387, 98-108.
186. Zamore, P. D. & Haley, B. (2005). Ribo-gnome: the big world of small RNAs. Science 309, 1519-1524.
187. Zhao, R. Y., Li, G. & Bukrinsky, M. I. (2011). Vpr-host interactions during HIV-1 viral life cycle. J Neuroimmune Pharmacol 6, 216-229.
188. Zimmerman, E. S., Sherman, M. P., Blackett, J. L., Neidleman, J. A., Kreis, C., Mundt, P., Williams, S. A., Warmerdam, M., Kahn, J. & other authors (2006). Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo. J Virol 80, 10407-10418.